Skip to content
TheChatArchiveThe Chat Archive
gpt-4o-search-preview· OpenAIHugging Face LMArena Search Arena 24K

SphK2 is abnormally expressed in a variety of malignant tumors and promotes tumor cell…

From a Chatbot Arena battleThe same person sent this prompt to two anonymous models at once. Compare it with Geminigemini-2.5-pro-exp-03-25-grounding’s answer.
  1. User

    SphK2 is abnormally expressed in a variety of malignant tumors and promotes tumor cell proliferation.

  2. Assistant

    Sphingosine kinase 2 (SphK2) is an enzyme encoded by the SPHK2 gene in humans. It catalyzes the phosphorylation of sphingosine into sphingosine-1-phosphate (S1P), a lipid signaling molecule involved in various cellular processes, including migration, proliferation, and apoptosis. S1P also plays a role in several types of cancer by promoting angiogenesis and tumorigenesis.

    Research indicates that SphK2 is abnormally expressed in various malignant tumors and contributes to tumor cell proliferation. For instance, elevated SphK2 expression has been observed in breast cancer, where it may influence cancer cell proliferation and resistance to chemotherapy.

    Given its role in cancer progression, SphK2 has become a target for therapeutic intervention. Inhibitors like opaganib are being investigated for their potential to modulate SphK2 activity and impede tumor growth.

    In summary, SphK2's abnormal expression in various cancers and its promotion of tumor cell proliferation underscore its significance in cancer biology and its potential as a therapeutic target.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.